Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis.

Charbonnel B, Simon D, Dallongeville J, Bureau I, Dejager S, Levy-Bachelot L, Gourmelen J, Detournay B

DOI: 10.1007/s41669-017-0050-3
Published: 2018 Jun
Container: PharmacoEconomics - open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s41669-017-0050-3,
  title = {Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis.},
  author = {Charbonnel B and Simon D and Dallongeville J and Bureau I and Dejager S and Levy-Bachelot L and Gourmelen J and Detournay B},
  year = {2018},
  journal = {PharmacoEconomics - open},
  doi = {10.1007/s41669-017-0050-3},
  url = {https://doi.org/10.1007/s41669-017-0050-3}
}

RIS

TY  - JOUR
TI  - Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis.
AU  - Charbonnel B
AU  - Simon D
AU  - Dallongeville J
AU  - Bureau I
AU  - Dejager S
AU  - Levy-Bachelot L
AU  - Gourmelen J
AU  - Detournay B
PY  - 2018
JO  - PharmacoEconomics - open
DO  - 10.1007/s41669-017-0050-3
UR  - https://doi.org/10.1007/s41669-017-0050-3
ER  -

APA

B, C., D, S., J, D., I, B., S, D., L, L., J, G., & B, D. (2018). Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis.. PharmacoEconomics - open. https://doi.org/10.1007/s41669-017-0050-3

Source records

pubmed · retrieved 2026-09-25T13:11:29.605Z